Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study

NCT03333356 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03333356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 19, 2018
Completion date
December 31, 2027
Enrollment
81 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

patients with high-risk mibc